[ET Net News Agency, 30 August 2021] Alphamab Oncology (09966) said its loss was
RMB267.36 million for the six months ended 30 June 2021, compared to the loss of RMB103.1
million of the same period last year. Basic loss per share was RMB0.29. No dividend will
be distributed.
It did not generate any revenue from product sales. (RC)